PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Rupendra Shrestha

Department of Natural and Applied Sciences, Nexus Institute of Research and Innovation (NIRI), Lalitpur, Nepal. Electronic address: rupendra.shrestha@nirinepal.org.

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 13, 2026 · JOURNAL ARTICLE

Bifidobacterium and the gut-immune axis: Mechanistic insights and therapeutic potential.

Microbiological Research

This narrative review synthesizes mechanistic and preclinical evidence on Bifidobacterium immunomodulation but explicitly states outcomes remain heterogeneous and lacks definitive clinical trials, positioning it as an exploratory synthesis raising questions rather than settling them.

Hypothesis-GeneratingInflammatory Bowel Diseases Rupendra Shrestha Loganathan Krishnamoorthy

Study details

DesignNarrative review

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support